Last checked at 22 Jun 2016 12:35
Venture Life Group plc
("Venture Life" or "the Group")
Result of AGM
Bracknell, UK - 22 June 2016: Venture Life Group plc (AIM: VLG), the international consumer self-care group focused on developing, manufacturing and commercialising products for the ageing population, announces that at its Annual General Meeting held earlier today all resolutions were duly passed.
The Group will be issuing a pre-close trading statement for the first half of the financial year ending 31 December 2016 towards the end of July 2016.
- Ends -
For further information please contact:
Venture Life Group PLC
Jerry Randall, Chief Executive Officer +44 (0) 1344 742870
James Hunter, Chief Financial Officer
Panmure Gordon (UK) Limited (Nominated Adviser and Broker) Freddy Crossley +44 (0) 20 7886 2500
Peter Steel
Duncan Monteith Corporate Finance
Tom SalvesenCorporate Broking
Square1 Consulting
David Bick +44 (0) 20 7929 5599
Brian Alexander
About Venture Life
Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the ageing population. The Group's product range and pipeline currently includes the UltraDEX oral care products range, food supplements for lowering cholesterol and maintaining brain function, dermo-cosmetics for addressing the signs of ageing, and medical devices for improving minor aches and pains, dry eyes and itchy skin.
The products, which typically are recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies supplied by the Group's international distribution partners.
Through its manufacturing company, Biokosmes, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.